Perrigo Balance Sheet Health
Financial Health criteria checks 1/6
Perrigo has a total shareholder equity of $4.7B and total debt of $4.1B, which brings its debt-to-equity ratio to 86.5%. Its total assets and total liabilities are $10.6B and $6.0B respectively. Perrigo's EBIT is $257.8M making its interest coverage ratio 1.2. It has cash and short-term investments of $658.5M.
Key information
86.5%
Debt to equity ratio
US$4.06b
Debt
| Interest coverage ratio | 1.2x |
| Cash | US$658.50m |
| Equity | US$4.69b |
| Total liabilities | US$5.95b |
| Total assets | US$10.64b |
Recent financial health updates
These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
May 29
These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
Feb 01Here's Why Perrigo (NYSE:PRGO) Has A Meaningful Debt Burden
Jul 13Recent updates
These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
May 29Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price
Mar 27These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
Feb 01The Market Doesn't Like What It Sees From Perrigo Company plc's (NYSE:PRGO) Revenues Yet
Dec 28Perrigo's New Chapter: Its Bold Turnaround Plan Is Worth Buying
Nov 15The Prognosis For Perrigo
Aug 30Perrigo Outlook Healed By Repositioning
Jun 12Perrigo raises dividend by 5% to $0.273/share
Feb 21Perrigo: Still Languishing But Short-Term Trend Offers Encouragement
Jan 18Perrigo Non-GAAP EPS of $0.56 misses by $0.11, revenue of $1.1B misses by $40M, lowers FY adj. EPS guidance
Nov 08Perrigo to invest $170M to expand baby formula manufacturing, buys Nestlé Gateway plant
Nov 01Perrigo Company plc Is Back On Track
Oct 20Perrigo to face FDA AdCom meeting for OTC contraceptive
Sep 12Perrigo responds to 'misleading and inaccurate information' on Zantac claims
Aug 17Perrigo reports Q2 mixed results; raises FY22 organic net sales growth outlook
Aug 09Perrigo declares $0.26 dividend
Aug 02Perrigo: HRA Acquisition To Drive Significant Growth
Jul 20Perrigo unit seeks FDA over-the-counter approval for birth control pill Opill
Jul 11Perrigo: The Longer The Base The Higher In Space
Apr 12The Prognosis For Perrigo
Jan 09Perrigo: Honing In On A Long Term Bottom
Dec 16Perrigo Company plc (NYSE:PRGO) Shares Could Be 39% Below Their Intrinsic Value Estimate
Oct 17Perrigo: HRA Acquisition Is A Step In The Right Direction, But Fundamental Concerns Remain
Sep 24Here's Why Perrigo (NYSE:PRGO) Has A Meaningful Debt Burden
Jul 13Perrigo Company (PRGO) Presents At Evercore ISI Consumer & Retail Virtual Summit Conference - Slideshow
Jun 21Are Investors Undervaluing Perrigo Company plc (NYSE:PRGO) By 44%?
Jun 21Financial Position Analysis
Short Term Liabilities: PRGO's short term assets ($2.8B) exceed its short term liabilities ($1.6B).
Long Term Liabilities: PRGO's short term assets ($2.8B) do not cover its long term liabilities ($4.4B).
Debt to Equity History and Analysis
Debt Level: PRGO's net debt to equity ratio (72.5%) is considered high.
Reducing Debt: PRGO's debt to equity ratio has increased from 56.3% to 86.5% over the past 5 years.
Debt Coverage: PRGO's debt is not well covered by operating cash flow (9.5%).
Interest Coverage: PRGO's interest payments on its debt are not well covered by EBIT (1.2x coverage).